Clarus Lifesciences III L.P. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-12 4:30 pm Sale | 2022-01-10 | 13D | ESSA Pharma Inc. EPIX | Clarus Lifesciences III L.P. | 2,187,912 4.960% | -1,291,202 (-37.11%) | Filing |